[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Age Related Macular Degeneration Drug Market Professional Survey Report Forecast 2017-2021

May 2017 | 133 pages | ID: G01EB3A0FE8EN
S&P Consulting

US$ 2,720.00 US$ 3,400.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Age Related Macular Degeneration Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Roche/Genentech
Novartis
Regeneron
Bayer
Valeant
Allergan
Alimera Sciences
Ophthotech
Acucela

By types, the market can be split into

Type 1
Type 2
Type 3

By Application, the market can be split into

Application 1
Application 2
Application 3

By Regions, this report covers (we can add the regions/countries as you want)

North America
China
Europe
Southeast Asia
Japan
India
Global Age Related Macular Degeneration Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF AGE RELATED MACULAR DEGENERATION DRUG

1.1 Definition and Specifications of Age Related Macular Degeneration Drug
  1.1.1 Definition of Age Related Macular Degeneration Drug
  1.1.2 Specifications of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Applications of Age Related Macular Degeneration Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF AGE RELATED MACULAR DEGENERATION DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug
2.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug
2.4 Industry Chain Structure of Age Related Macular Degeneration Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF AGE RELATED MACULAR DEGENERATION DRUG

3.1 Capacity and Commercial Production Date of Global Age Related Macular Degeneration Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Age Related Macular Degeneration Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Age Related Macular Degeneration Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Age Related Macular Degeneration Drug Major Manufacturers in 2016

4 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017 Global Age Related Macular Degeneration Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Age Related Macular Degeneration Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017 Global Age Related Macular Degeneration Drug Sales and Growth Rate Analysis
  4.3.2 2016 Age Related Macular Degeneration Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017 Global Age Related Macular Degeneration Drug Sales Price
  4.4.2 2016 Age Related Macular Degeneration Drug Sales Price Analysis (Company Segment)

5 AGE RELATED MACULAR DEGENERATION DRUG REGIONAL MARKET ANALYSIS

5.1 North America Age Related Macular Degeneration Drug Market Analysis
  5.1.1 North America Age Related Macular Degeneration Drug Market Overview
  5.1.2 North America 2012-2017 Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017 Age Related Macular Degeneration Drug Sales Price Analysis
  5.1.4 North America 2016 Age Related Macular Degeneration Drug Market Share Analysis
5.2 China Age Related Macular Degeneration Drug Market Analysis
  5.2.1 China Age Related Macular Degeneration Drug Market Overview
  5.2.2 China 2012-2017 Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017 Age Related Macular Degeneration Drug Sales Price Analysis
  5.2.4 China 2016 Age Related Macular Degeneration Drug Market Share Analysis
5.3 Europe Age Related Macular Degeneration Drug Market Analysis
  5.3.1 Europe Age Related Macular Degeneration Drug Market Overview
  5.3.2 Europe 2012-2017 Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017 Age Related Macular Degeneration Drug Sales Price Analysis
  5.3.4 Europe 2016 Age Related Macular Degeneration Drug Market Share Analysis
5.4 Southeast Asia Age Related Macular Degeneration Drug Market Analysis
  5.4.1 Southeast Asia Age Related Macular Degeneration Drug Market Overview
  5.4.2 Southeast Asia 2012-2017 Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017 Age Related Macular Degeneration Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Age Related Macular Degeneration Drug Market Share Analysis
5.5 Japan Age Related Macular Degeneration Drug Market Analysis
  5.5.1 Japan Age Related Macular Degeneration Drug Market Overview
  5.5.2 Japan 2012-2017 Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017 Age Related Macular Degeneration Drug Sales Price Analysis
  5.5.4 Japan 2016 Age Related Macular Degeneration Drug Market Share Analysis
5.6 India Age Related Macular Degeneration Drug Market Analysis
  5.6.1 India Age Related Macular Degeneration Drug Market Overview
  5.6.2 India 2012-2017 Age Related Macular Degeneration Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017 Age Related Macular Degeneration Drug Sales Price Analysis
  5.6.4 India 2016 Age Related Macular Degeneration Drug Market Share Analysis

6 GLOBAL 2012-2017 AGE RELATED MACULAR DEGENERATION DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017 Age Related Macular Degeneration Drug Sales by Type
6.2 Different Types of Age Related Macular Degeneration Drug Product Interview Price Analysis
6.3 Different Types of Age Related Macular Degeneration Drug Product Driving Factors Analysis
  6.3.1 General keyboard membrane of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
  6.3.2 Transparent keyboard membrane of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
  6.3.3 Simulation keyboard membrane of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
  6.3.4 Colorful keyboard membrane of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
  6.3.5 Other of Age Related Macular Degeneration Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017 AGE RELATED MACULAR DEGENERATION DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017 Age Related Macular Degeneration Drug Consumption by Application
7.2 Different Application of Age Related Macular Degeneration Drug Product Interview Price Analysis
7.3 Different Application of Age Related Macular Degeneration Drug Product Driving Factors Analysis
  7.3.1 Office Use of Age Related Macular Degeneration Drug Growth Driving Factor Analysis
  7.3.2 Personal Use of Age Related Macular Degeneration Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF AGE RELATED MACULAR DEGENERATION DRUG

8.1 Roche/Genentech
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Picture and Specifications
  8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Novartis
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Picture and Specifications
  8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Regeneron
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Picture and Specifications
  8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Bayer
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Picture and Specifications
  8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Valeant
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Picture and Specifications
  8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Allergan
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Picture and Specifications
  8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Alimera Sciences
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Picture and Specifications
  8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Ophthotech
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Picture and Specifications
  8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Acucela
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Picture and Specifications
  8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

9 DEVELOPMENT TREND OF ANALYSIS OF AGE RELATED MACULAR DEGENERATION DRUG MARKET

9.1 Global Age Related Macular Degeneration Drug Market Trend Analysis
  9.1.1 Global 2017-2021 Age Related Macular Degeneration Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2021 Age Related Macular Degeneration Drug Sales Price Forecast
9.2 Age Related Macular Degeneration Drug Regional Market Trend
  9.2.1 North America 2017-2021 Age Related Macular Degeneration Drug Consumption Forecast
  9.2.2 China 2017-2021 Age Related Macular Degeneration Drug Consumption Forecast
  9.2.3 Europe 2017-2021 Age Related Macular Degeneration Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2021 Age Related Macular Degeneration Drug Consumption Forecast
  9.2.5 Japan 2017-2021 Age Related Macular Degeneration Drug Consumption Forecast
  9.2.6 India 2017-2021 Age Related Macular Degeneration Drug Consumption Forecast
9.3 Age Related Macular Degeneration Drug Market Trend (Product Type)
9.4 Age Related Macular Degeneration Drug Market Trend (Application)

10 AGE RELATED MACULAR DEGENERATION DRUG MARKETING TYPE ANALYSIS

10.1 Age Related Macular Degeneration Drug Regional Marketing Type Analysis
10.2 Age Related Macular Degeneration Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Age Related Macular Degeneration Drug by Regions
10.4 Age Related Macular Degeneration Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF AGE RELATED MACULAR DEGENERATION DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Age Related Macular Degeneration Drug
Table Product Specifications of Age Related Macular Degeneration Drug
Table Classification of Age Related Macular Degeneration Drug
Figure Global Production Market Share of Age Related Macular Degeneration Drug by Type in 2016
Table Applications of Age Related Macular Degeneration Drug
Figure Global Consumption Volume Market Share of Age Related Macular Degeneration Drug by Application in 2016
Figure Market Share of Age Related Macular Degeneration Drug by Regions
Figure North America Age Related Macular Degeneration Drug Market Size (2011-2021)
Figure China Age Related Macular Degeneration Drug Market Size (2011-2021)
Figure Europe Age Related Macular Degeneration Drug Market Size (2011-2021)
Figure Southeast Asia Age Related Macular Degeneration Drug Market Size (2011-2021)
Figure Japan Age Related Macular Degeneration Drug Market Size (2011-2021)
Figure India Age Related Macular Degeneration Drug Market Size (2011-2021)
Table Age Related Macular Degeneration Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Age Related Macular Degeneration Drug in 2016
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Industry Chain Structure of Age Related Macular Degeneration Drug
Table Capacity and Commercial Production Date of Global Age Related Macular Degeneration Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Age Related Macular Degeneration Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Age Related Macular Degeneration Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Age Related Macular Degeneration Drug Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Age Related Macular Degeneration Drug 2012-2017
Figure Global 2012-2017 Age Related Macular Degeneration Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017 Age Related Macular Degeneration Drug Market Size (Value) and Growth Rate
Table 2012-2017 Global Age Related Macular Degeneration Drug Capacity and Growth Rate
Table 2016 Global Age Related Macular Degeneration Drug Capacity List (Company Segment)
Table 2012-2017 Global Age Related Macular Degeneration Drug Sales and Growth Rate
Table 2016 Global Age Related Macular Degeneration Drug Sales List (Company Segment)
Table 2012-2017 Global Age Related Macular Degeneration Drug Sales Price
Table 2016 Global Age Related Macular Degeneration Drug Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Age Related Macular Degeneration Drug 2012-2017
Figure North America 2012-2017 Age Related Macular Degeneration Drug Sales Price
Figure North America 2016 Age Related Macular Degeneration Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Age Related Macular Degeneration Drug 2012-2017
Figure China 2012-2017 Age Related Macular Degeneration Drug Sales Price
Figure China 2016 Age Related Macular Degeneration Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Age Related Macular Degeneration Drug 2012-2017
Figure Europe 2012-2017 Age Related Macular Degeneration Drug Sales Price
Figure Europe 2016 Age Related Macular Degeneration Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Age Related Macular Degeneration Drug 2012-2017
Figure Southeast Asia 2012-2017 Age Related Macular Degeneration Drug Sales Price
Figure Southeast Asia 2016 Age Related Macular Degeneration Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Age Related Macular Degeneration Drug 2012-2017
Figure Japan 2012-2017 Age Related Macular Degeneration Drug Sales Price
Figure Japan 2016 Age Related Macular Degeneration Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Age Related Macular Degeneration Drug 2012-2017
Figure India 2012-2017 Age Related Macular Degeneration Drug Sales Price
Figure India 2016 Age Related Macular Degeneration Drug Sales Market Share
Table Global 2012-2017 Age Related Macular Degeneration Drug Sales by Type
Table Different Types Age Related Macular Degeneration Drug Product Interview Price
Table Global 2012-2017 Age Related Macular Degeneration Drug Sales by Application
Table Different Application Age Related Macular Degeneration Drug Product Interview Price
Table Roche/Genentech Basic Information List
Table Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche/Genentech Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Regeneron Basic Information List
Table Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Regeneron Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Valeant Basic Information List
Table Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Valeant Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alimera Sciences Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Ophthotech Basic Information List
Table Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ophthotech Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Acucela Basic Information List
Table Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acucela Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Figure Global 2017-2021 Age Related Macular Degeneration Drug Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2021 Age Related Macular Degeneration Drug Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2021 Age Related Macular Degeneration Drug Sales Price Forecast
Figure North America 2017-2021 Age Related Macular Degeneration Drug Consumption Volume and Growth Rate Forecast
Figure China 2017-2021 Age Related Macular Degeneration Drug Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2021 Age Related Macular Degeneration Drug Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2021 Age Related Macular Degeneration Drug Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2021 Age Related Macular Degeneration Drug Consumption Volume and Growth Rate Forecast
Figure India 2017-2021 Age Related Macular Degeneration Drug Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Age Related Macular Degeneration Drug by Types 2017-2021
Table Global Consumption Volume of Age Related Macular Degeneration Drug by Applications 2017-2021
Table Traders or Distributors with Contact Information of Age Related Macular Degeneration Drug by Regions

COMPANIES MENTIONED

Roche/Genentech, Novartis, Regeneron, Bayer, Valeant, Allergan, Alimera Sciences, Ophthotech, Acucela, Ohr Pharmaceuticals


More Publications